nei THIS MONTH IN
PSYCHOPHARMACOLOGY
Browsing articles in "Eating Disorders"

 
FDA Warns of Possible Increased Risk of Cancer With Lorcaserin
January 30, 2020   

In 2016, the World Health Organization reported that more than 1.9 billion adults were overweight and of these over 650 million were classified as obese. Overweight and obese patients are at increased risk of developing a host of cardiometabolic diseases and certain cancers, which subsequently increases...
 Continue reading
Highlights from the 2017 APA Annual Meeting
June 8, 2017   

The 2017 APA annual meeting, held in NEI's hometown of San Diego, was themed "Prevention Through Partnership" and included more than 400 sessions. Here, we provide highlights of the meeting, including NEI's podcast interviews with expert presenters, key research from the poster sessions, and NEI's debut live concert--the NEI PsychopharmaJam.
 Continue reading
September News and New Research
September 1, 2014   

SSRI discontinuation before pregnancy does not reduce risk of miscarriage, US FDA approves Contrave for weight management, maternal immune activation and increased risk for schizophrenia in offspring, and other news.
 Continue reading (Members only)
Top of Page